PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced data from a Phase 4 clinical trial evaluating the symptom stability, safety and tolerability of Cobenfy (xanomeline ...
Reduced Gray Matter may be seen in bipolar patients on atypical antipsychotics Source: Michèle Hilbers/Unsplash While atypical anti-psychotics (AAPs) are a vital part of treating disorders with ...
What Is Bysanti, and Why Does It Matter? Bysanti (milsaperidone) is a new FDA-approved oral medicine for treating certain mental health conditions in adults. It belongs to a group of medicines called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results